BackGenetic Technologies Overview

Genetic Technologies Current Assets

Track Genetic Technologies's current assets ($3.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$3.70M
↓ 64.80% YoYΔ $-6.80M vs prior year quarter

Peer average

Loading

Genetic Technologies Current Assets History

Loading

Genetic Technologies vs. peers: Current Assets Comparison

Loading

Genetic Technologies Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Genetic Technologies (GENE) FAQ

Genetic Technologies (GENE) currently reports a current assets of $3.7M as of June 2024. That compares with $10M in the prior-year period — down 64.8% year over year. Use the charts on this page to explore Genetic Technologies's current assets history and peer comparisons.

Genetic Technologies's current assets decreased from $10M to $3.7M — a 64.8% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Genetic Technologies reported $3.7M in current assets as of June 2024. That compares with $10M in the prior-year period — down 64.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $3.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Genetic Technologies, and consider following GENE for alerts when major investors trade the stock.

Genetic Technologies is classified in the Healthcare sector. On current assets, it currently shows $3.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GENE with unrelated industries.